Zydus Lifesciences Limited
Simbols: ZYDUSLIFE.NS
NSE
981.35
INRTirgus cena šodien
32.9550
P/E koeficients
-2.1529
PEG koeficients
987.46B
MRK Cap
- 0.01%
DIV ienesīgums
Zydus Lifesciences Limited (ZYDUSLIFE-NS) Finanšu pārskati
Bilance
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 14204 | 35048 | 11272 | ||||||||||||||||||||
balance-sheet.row.short-term-investments | 0 | 9326 | 28470 | 4620 | ||||||||||||||||||||
balance-sheet.row.net-receivables | 0 | 44254 | 50324 | 43498 | ||||||||||||||||||||
balance-sheet.row.inventory | 0 | 34133 | 37194 | 32362 | ||||||||||||||||||||
balance-sheet.row.other-current-assets | 0 | 7573 | 48 | 28 | ||||||||||||||||||||
balance-sheet.row.total-current-assets | 0 | 100164 | 122614 | 87160 | ||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 68267 | 64226 | 63332 | ||||||||||||||||||||
balance-sheet.row.goodwill | 0 | 48044 | 53646 | 53465 | ||||||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 10905 | 11272 | 12363 | ||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 58949 | 64918 | 65828 | ||||||||||||||||||||
balance-sheet.row.long-term-investments | 0 | 9273 | 9348 | 6312 | ||||||||||||||||||||
balance-sheet.row.tax-assets | 0 | 12624 | 10958 | 10744 | ||||||||||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 8287 | 5890 | 5471 | ||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 157400 | 155340 | 151687 | ||||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.total-assets | 0 | 257564 | 277954 | 238847 | ||||||||||||||||||||
balance-sheet.row.account-payables | 0 | 21250 | 21378 | 22059 | ||||||||||||||||||||
balance-sheet.row.short-term-debt | 0 | 11751 | 38427 | 39830 | ||||||||||||||||||||
balance-sheet.row.tax-payables | 0 | 1568 | 418 | 884 | ||||||||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 198 | 3782 | 6246 | ||||||||||||||||||||
Deferred Revenue Non Current | 0 | 295 | 287 | 227 | ||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||||||||||||
balance-sheet.row.other-current-liab | 0 | 2705 | 345 | 241 | ||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 5374 | 9022 | 10938 | ||||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 317 | 249 | 241 | ||||||||||||||||||||
balance-sheet.row.total-liab | 0 | 60681 | 87416 | 89551 | ||||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.common-stock | 0 | 1012 | 1024 | 1024 | ||||||||||||||||||||
balance-sheet.row.retained-earnings | 0 | 171898 | 154958 | 113842 | ||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 248 | 12014 | 13057 | ||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 2000 | 2000 | 2000 | ||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 175158 | 169996 | 129923 | ||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 257564 | 277954 | 238847 | ||||||||||||||||||||
balance-sheet.row.minority-interest | 0 | 21725 | 20542 | 19373 | ||||||||||||||||||||
balance-sheet.row.total-equity | 0 | 196883 | 190538 | 149296 | ||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | ||||||||||||||||||||
Total Investments | 0 | 14253 | 9687 | 6867 | ||||||||||||||||||||
balance-sheet.row.total-debt | 0 | 11949 | 42209 | 46076 | ||||||||||||||||||||
balance-sheet.row.net-debt | 0 | 7071 | 35631 | 39424 |
Naudas plūsmas pārskats
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 25827 | 52323 | 22848 | ||||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 7227 | 7361 | 7248 | ||||||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 0 | ||||||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 0 | 0 | ||||||||||||||||||||
cash-flows.row.change-in-working-capital | 0 | -2358 | -3515 | 1868 | ||||||||||||||||||||
cash-flows.row.account-receivables | 0 | -8485 | -1817 | 4313 | ||||||||||||||||||||
cash-flows.row.inventory | 0 | 4407 | -5255 | -4797 | ||||||||||||||||||||
cash-flows.row.account-payables | 0 | -1708 | -1203 | 1709 | ||||||||||||||||||||
cash-flows.row.other-working-capital | 0 | 3428 | 4760 | 643 | ||||||||||||||||||||
cash-flows.row.other-non-cash-items | 0 | -3808 | -35128 | 966 | ||||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -10309 | -12026 | -8540 | ||||||||||||||||||||
cash-flows.row.acquisitions-net | 0 | 1146 | 2071 | 1035 | ||||||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | -2606 | -7837 | -400 | ||||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 23356 | 751 | 101 | ||||||||||||||||||||
cash-flows.row.other-investing-activites | 0 | 125 | 28585 | 579 | ||||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | 11712 | 11544 | -7225 | ||||||||||||||||||||
cash-flows.row.debt-repayment | 0 | -9960 | -14208 | -25683 | ||||||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 18592 | 0 | 9866 | ||||||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | -8632 | 0 | -8337 | ||||||||||||||||||||
cash-flows.row.dividends-paid | 0 | -2671 | -3722 | -15 | ||||||||||||||||||||
cash-flows.row.other-financing-activites | 0 | -41333 | 9247 | -1320 | ||||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -44004 | -8683 | -25489 | ||||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 66 | 86 | -42 | ||||||||||||||||||||
cash-flows.row.net-change-in-cash | 0 | -5338 | 23729 | -905 | ||||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 5731 | 34601 | 10872 | ||||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 11069 | 10872 | 11777 | ||||||||||||||||||||
cash-flows.row.operating-cash-flow | 0 | 26888 | 21041 | 32930 | ||||||||||||||||||||
cash-flows.row.capital-expenditure | 0 | -10309 | -12026 | -8540 | ||||||||||||||||||||
cash-flows.row.free-cash-flow | 0 | 16579 | 9015 | 24390 |
Peļņas vai zaudējumu aprēķina rinda
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 168778 | 148276 | 148215 | ||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 63101 | 58189 | 54800 | ||||||||||||||||||||
income-statement-row.row.gross-profit | 0 | 105677 | 90087 | 93415 | ||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||||||
income-statement-row.row.other-expenses | 0 | 1866 | 31 | 51 | ||||||||||||||||||||
income-statement-row.row.operating-expenses | 0 | 77149 | 65320 | 67152 | ||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 140250 | 123509 | 121952 | ||||||||||||||||||||
income-statement-row.row.interest-income | 0 | 757 | 688 | 503 | ||||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 1299 | 1144 | 1604 | ||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -1685 | 4102 | -2890 | ||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 1866 | 31 | 51 | ||||||||||||||||||||
income-statement-row.row.total-operating-expenses | 0 | -1685 | 4102 | -2890 | ||||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 1299 | 1144 | 1604 | ||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 7227 | 7361 | 7248 | ||||||||||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||||||||||||||||||
income-statement-row.row.operating-income | 0 | 28528 | 24741 | 27356 | ||||||||||||||||||||
income-statement-row.row.income-before-tax | 0 | 25897 | 28381 | 22848 | ||||||||||||||||||||
income-statement-row.row.income-tax-expense | 0 | 5878 | 5117 | 1472 | ||||||||||||||||||||
income-statement-row.row.net-income | 0 | 19603 | 44873 | 21336 |
Biežāk uzdotie jautājumi
Kas ir Zydus Lifesciences Limited (ZYDUSLIFE.NS) kopējie aktīvi?
Zydus Lifesciences Limited (ZYDUSLIFE.NS) kopējie aktīvi ir 257564000000.000.
Kādi ir uzņēmuma gada ieņēmumi?
Gada ieņēmumi ir N/A.
Kāda ir uzņēmuma peļņas norma?
Uzņēmuma peļņas norma ir 0.659.
Kāda ir uzņēmuma brīvā naudas plūsma?
Brīvā naudas plūsma ir 14.570.
Kāda ir uzņēmuma neto peļņas norma?
Neto peļņas norma ir 0.161.
Kādi ir uzņēmuma kopējie ieņēmumi?
Kopējie ieņēmumi ir 0.239.
Kāda ir Zydus Lifesciences Limited (ZYDUSLIFE.NS) tīrā peļņa (tīrie ienākumi)?
Tīrā peļņa (tīrie ienākumi) ir 19603000000.000.
Kāds ir uzņēmuma kopējais parāds?
Kopējais parāds ir 11949000000.000.
Kāds ir pamatdarbības izdevumu skaits?
Darbības izdevumi ir 77149000000.000.
Kāds ir uzņēmuma skaidrās naudas rādītājs?
Uzņēmuma nauda ir 0.000.